314 related articles for article (PubMed ID: 29108822)
1. The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1).
Guo CJ; Leung PSC; Zhang W; Ma X; Gershwin ME
Autoimmun Rev; 2018 Jan; 17(1):78-85. PubMed ID: 29108822
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune polyglandular syndrome type 1 in Russian patients: clinical variants and autoimmune regulator mutations.
Orlova EM; Bukina AM; Kuznetsova ES; Kareva MA; Zakharova EU; Peterkova VA; Dedov II
Horm Res Paediatr; 2010; 73(6):449-57. PubMed ID: 20407228
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.
Meloni A; Furcas M; Cetani F; Marcocci C; Falorni A; Perniola R; Pura M; Bøe Wolff AS; Husebye ES; Lilic D; Ryan KR; Gennery AR; Cant AJ; Abinun M; Spickett GP; Arkwright PD; Denning D; Costigan C; Dominguez M; McConnell V; Willcox N; Meager A
J Clin Endocrinol Metab; 2008 Nov; 93(11):4389-97. PubMed ID: 18728167
[TBL] [Abstract][Full Text] [Related]
4. [AIRE gene mutation in polyglandular syndrome type 1].
Martínez López MM; González Casado I; Alvarez Doforno R; Delgado Cerviño E; Gracia Bouthelier R
An Pediatr (Barc); 2006 Jun; 64(6):583-7. PubMed ID: 16792967
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease.
F Magitta N; Pura M; S Bøe Wolff A; Vanuga P; Meager A; M Knappskog P; Husebye ES
Eur J Endocrinol; 2008 May; 158(5):705-9. PubMed ID: 18426830
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis in autoimmune polyendocrine syndrome type I: a possible complication or a non-endocrine minor component?
Poojary SA; Lodha N; Gupta N
Indian J Dermatol Venereol Leprol; 2015; 81(2):166-9. PubMed ID: 25751334
[TBL] [Abstract][Full Text] [Related]
7. [Autoimmune polyglandular syndromes].
Lankisch TO; Jaeckel E; Strassburg CP; Manns MP
Internist (Berl); 2005 Jul; 46(7):750-8. PubMed ID: 15947901
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune polyendocrine syndrome type 1: Clinical manifestations, pathogenetic features, and management approach.
Bjørklund G; Pivin M; Hangan T; Yurkovskaya O; Pivina L
Autoimmun Rev; 2022 Aug; 21(8):103135. PubMed ID: 35690244
[TBL] [Abstract][Full Text] [Related]
9. The autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy or autoimmune polyglandular syndrome type 1.
Lankisch TO; Jaeckel E; Strassburg CP
Semin Liver Dis; 2009 Aug; 29(3):307-14. PubMed ID: 19676003
[TBL] [Abstract][Full Text] [Related]
10. A new mutation site in the AIRE gene causes autoimmune polyendocrine syndrome type 1.
Zhu W; Hu Z; Liao X; Chen X; Huang W; Zhong Y; Zeng Z
Immunogenetics; 2017 Oct; 69(10):643-651. PubMed ID: 28540407
[TBL] [Abstract][Full Text] [Related]
11. [Autoimmune polyendocrine syndrome (APS)].
Warzée E; Legros JJ; Geenen V
Rev Med Liege; 2002 Nov; 57(11):710-4. PubMed ID: 12564102
[TBL] [Abstract][Full Text] [Related]
12. [APS I--a severe autoimmune disease with endocrine and non-endocrine symptoms].
Gustafsson J; Alimohammadi M; Ekwall O; Gebre-Medhin G; Halldin-Stenlid M; Hedstrand H; Landgren E; Nilsson T; Rorsman F; Sköldberg F; Winqvist O; Kämpe O
Lakartidningen; 2004 Jun; 101(24):2096-8, 2101-3. PubMed ID: 15282984
[TBL] [Abstract][Full Text] [Related]
13. [Atypical clinical presentation of autoimmune polyglandular syndrome type 4].
Krysiak R; Kobielusz-Gembala I; Okopień B
Przegl Lek; 2011; 68(6):339-41. PubMed ID: 22039674
[TBL] [Abstract][Full Text] [Related]
14. [Polyglandular autoimmune syndromes : An overview].
Komminoth P
Pathologe; 2016 May; 37(3):253-7. PubMed ID: 27099223
[TBL] [Abstract][Full Text] [Related]
15. Precocious presentation of autoimmune polyglandular syndrome type 2 associated with an AIRE mutation.
Resende E; Gόmez GN; Nascimento M; Loidi L; Saborido Fiaño R; Cabanas Rodrίguez P; Castro-Feijoo L; Barreiro Conde J
Hormones (Athens); 2015; 14(2):312-6. PubMed ID: 25402387
[TBL] [Abstract][Full Text] [Related]
16. Assessment of autoantibodies to interferon-ω in patients with autoimmune polyendocrine syndrome type 1: using a new immunoprecipitation assay.
Larosa MDP; Mackenzie R; Burne P; Garelli S; Barollo S; Masiero S; Rubin B; Chen S; Furmaniak J; Betterle C; Smith BR
Clin Chem Lab Med; 2017 Jun; 55(7):1003-1012. PubMed ID: 28099118
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune hypogonadism as part of an autoimmune polyglandular syndrome.
Maclaren N; Chen QY; Kukreja A; Marker J; Zhang CH; Sun ZS
J Soc Gynecol Investig; 2001; 8(1 Suppl Proceedings):S52-4. PubMed ID: 11223374
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway.
Myhre AG; Halonen M; Eskelin P; Ekwall O; Hedstrand H; Rorsman F; Kämpe O; Husebye ES
Clin Endocrinol (Oxf); 2001 Feb; 54(2):211-7. PubMed ID: 11207636
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune polyglandular syndromes: interplay between the immune and the endocrine systems leading to a diverse set of clinical diseases and new insights into immune regulation.
Lebovitz HE
Diabetes Technol Ther; 2013 Jun; 15 Suppl 2():S2-21-S2-28. PubMed ID: 23786295
[TBL] [Abstract][Full Text] [Related]
20. Polyglandular autoimmune syndrome type I.
Proust-Lemoine E; Saugier-Veber P; Wémeau JL
Presse Med; 2012 Dec; 41(12 P 2):e651-62. PubMed ID: 23182677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
